Review
Published on 23 Aug 2017
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
in Cancer Molecular Targets and Therapeutics
Frontiers in Pharmacology
doi 10.3389/fphar.2017.00561
- 220,427 views
- 1,607 citations
